Kenneth M. Cohen, President and CEO at Somaxon Pharmaceuticals, Inc. (SOMX), sold 50 shares at $15.00 ($750) on 2006-11-07, disclosed to the SEC on 2006-11-09.
Scheduled sale ($750) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MBVX | BUY | 2014-12-18 | $5K | — | Filing → |
| MBVX | BUY | 2014-12-17 | $10K | — | Filing → |
| SOMX | SELL | 2007-04-27 | $360K | — | Filing → |